TrialNature medicine2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Rodabe N Amaria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
486 papers cite itlatest 60 shown
this paperpooled ittrialcites it